Castle Biosciences Earnings
NASDAQ: CSTLHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Mon, Nov 2, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.38
Castle Biosciences earnings summary
Castle Biosciences is scheduled to report Sep/2026 earnings on Nov 2, 2026, with analysts expecting EPS of $-0.38. In its most recent report on Jul 30, 2026 (Q2 2026), CSTL posted EPS of $-0.07. Revenue for the quarter was $103.5 million.
Quarterly EPS is down 146.7% from the same quarter a year earlier. Across the last 16 reports, CSTL shares moved an average of 5.7% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
CSTL earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Jul 30, 2026 | — | $-0.07 | — | +14.4% |
| May 6, 2026 | — | $-0.49 | — | -3.5% |
| Jan 13, 2026 | — | $-0.06 | — | +5.6% |
| Nov 3, 2025 | — | $-0.02 | — | +1.2% |
| Aug 4, 2025 | — | $0.15 | — | +3.8% |
| May 5, 2025 | — | $-0.90 | — | -0.2% |
| Jan 13, 2025 | — | $0.32 | — | +6.0% |
| Nov 4, 2024 | — | $0.08 | — | -15.6% |
| Aug 5, 2024 | — | $0.31 | — | +0.6% |
| May 2, 2024 | — | $-0.09 | — | -0.4% |
| Jan 8, 2024 | — | $-0.08 | — | -4.3% |
| Nov 2, 2023 | — | $-0.26 | — | -4.4% |
| Aug 2, 2023 | — | $-0.70 | — | -5.4% |
| May 3, 2023 | — | $-1.10 | — | +2.8% |
| Feb 28, 2023 | — | $-0.78 | — | -21.1% |
| Nov 2, 2022 | — | $-0.77 | — | +2.1% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.